Where does iRhythm Holdings, Inc. 's cash flow data come from?

Every line is extracted from iRhythm Holdings, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	——	——	-$51.46M+65.8%	-$92.43M+29.8%	-$98.32M+24.3%
Depreciation and amortization	$20.57M-1.1%	$20.74M+0.1%	$20.78M+2.1%	$20.74M+7.6%	$20.79M+16.1%
Stock-based compensation	$86.43M+10.3%	$88.28M+16.2%	$83.19M-0.8%	$79.34M-9.5%	$78.33M-2.0%
Change in accounts receivable	$98.31M+26.8%	$95.43M+3.8%	$99.62M+1.6%	$89.32M-12.5%	$77.53M-25.9%
Change in inventories	$10.55M—	$8.51M—	——	——	——
Change in accounts payable	$7.66M—	$29.69M—	——	——	——
Change in other assets	——	——	——	——	-$8.64M-136%
Other working capital changes	$1.2M—	$967K—	$1.18M—	——	——
Change in deferred revenue	$797K—	$1.29M—	$1.19M—	$353K—	——
Net gains (losses) on investments	$6.32M+130%	$5.71M+200%	$4.73M+347%	$4.9M—	$2.75M—
Non-cash operating lease expense	$5.85M+12.2%	$5.74M+13.3%	$5.58M+5.3%	$5.39M-2.5%	$5.21M-8.2%
Debt issuance costs and discount amortization	$3.08M+2.1%	$3.06M+9.4%	$2.93M+34.8%	$3.03M+127%	$3.01M+408%
Net cash from operating activities	$62.58M—	$80.86M—	$73.88M—	——	——
Capital expenditures	$43.83M+30.5%	$46.34M+36.5%	$41.46M+2.1%	$35.47M-13.2%	$33.59M-19.6%
Acquired in-process research and development	$3.04M-90.7%	$3.04M-90.6%	$2.6M-91.9%	$34.37M—	$32.67M—
Net cash from investing activities	-$208.7M-3.8%	-$277.06M-125%	-$350.42M—	-$316.55M—	-$201.12M—
Proceeds from issuance of common stock	$11.03M+14.9%	$12.61M+48.8%	$12.64M+41.1%	$11.96M+34.8%	$9.6M+12.7%
Net cash from financing activities	$11.03M+29.7%	$12.61M-97.5%	$12.64M-97.5%	$11.81M-97.7%	$8.5M-98.3%
Effect of exchange rate changes on cash	-$38K—	$1K—	——	——	——
Net increase (decrease) in cash	-$135.13M—	-$183.59M—	——	——	——
Interest paid	——	——	——	——	——
Income taxes paid	$716K-45.0%	$1.2M+29.6%	$1.26M+34.0%	$1.21M+0.7%	$1.3M+14.9%
Accretion (Amortization) of Discounts and Premiums, Investments	$3.24M+205%	$3.13M+132%	$2.28M-14.0%	$1.47M-62.9%	$1.06M-77.9%
Amortization Of Debt Discount Premium	$3.08M+2.1%	$3.06M+9.4%	$2.93M+34.8%	$3.03M+127%	$3.01M+408%
Equity Securities, FV-NI, Gain (Loss)	$6.32M+130%	$5.71M+200%	$4.73M+347%	$4.9M—	$2.75M—
Operating lease liabilities	-$9.29M-16.4%	-$8.79M-14.0%	-$8.59M-20.5%	-$8.15M-14.3%	-$7.98M-6.7%
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——	——
Operating lease right-of-use asset amortization	$5.85M+12.2%	$5.74M+13.3%	$5.58M+5.3%	$5.39M-2.5%	$5.21M-8.2%
Provision for credit losses and contractual allowances	$98.08M+13.3%	$99.67M+35.7%	$100.89M+42.7%	$92.68M+37.0%	$86.6M—
Acquired in-process research and development	$3.04M-90.7%	$3.04M-90.6%	$2.6M-91.9%	$34.37M—	$32.67M—
Payments to Acquire Strategic Investments	$3.8M—	$2.3M—	$4.3M—	$42M—	——
Proceeds from issuance of common stock relating to employee stock plans	$11.03M+14.9%	$12.61M+48.8%	$12.64M+41.1%	$11.96M+34.8%	$9.6M+12.7%
Accrued payables for capital expenditures	——	——	——	——	——
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	-$38K—	$1K—	——	——	——
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount	$4.97M-23.9%	$5.26M-22.4%	$5.42M-25.9%	$5.82M-21.8%	$6.54M-11.5%
Operating Lease Payments	$16.14M+5.5%	$15.88M+4.6%	$15.69M+5.9%	$15.48M+6.4%	$15.31M+7.0%
Income Taxes Paid, Net	$716K-45.0%	$1.2M+29.6%	$1.26M+34.0%	$1.21M+0.7%	$1.3M+14.9%
Free cash flow	$18.75M—	$34.52M—	——	——	——
Free cash flow	$18.75M—	$34.52M—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does iRhythm Holdings, Inc. 's cash flow data come from?: Every line is extracted from iRhythm Holdings, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.